D.E. Shaw & Co’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
Other funds holding CTNM
D.E. Shaw & Co's CTNM Position: Q3 2026 in Review
D.E. Shaw & Co opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 11,357 shares worth $152K. The stake represents ﹤0.01% of the portfolio and ranks #4672 among its holdings.
118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.
- D.E. Shaw & Co held 11,357 shares of Contineum Therapeutics worth $152K as of Q3 2026.
- Contineum Therapeutics was a new D.E. Shaw & Co position in Q3 2026.
- Contineum Therapeutics made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q3 2026, its #4672 holding.
- 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.